stella
beta
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study — Stella
Recruiting
Back to Neuroendocrine Tumors trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Italy
European Institute of Oncology, IEO, IRCCS, Milan
View full record on ClinicalTrials.gov